Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Bokemeyer

Showing results (291-300 of 664) with videos related to

Pageof 67
Sort By:
Virchows Archiv : an International Journal of Pathology|December 14, 2023
Molecular and histopathological characterization of seminoma patients with highly elevated human chorionic gonadotropin levels in the serumChristoph Seidel, Finn-Ole Paulsen, Tim Nestler, et al.
Therapeutic Advances in Medical Oncology|June 4, 2026
Treatment options in platinum-refractory male germ cell cancers: current standards and future directionsMarco Oltrecolli, Domiziana Alaimo, Fabrizio Di Costanzo, et al.
Nature Reviews. Urology|March 9, 2021
Late adverse effects and quality of life in survivors of testicular germ cell tumourMichal Chovanec, Jakob Lauritsen, Mikkel Bandak, et al.
BMC Palliative Care|May 14, 2020
Evaluation of a communication skills training to facilitate addressing palliative care related topics in advanced cancer patients: study protocol of a multicenter randomized controlled trial (PALLI-KOM)Nele Harnischfeger, Hilke M Rath, Anneke Ullrich, et al.
International Journal of Molecular Sciences|October 13, 2021
Mebendazole Mediates Proteasomal Degradation of GLI Transcription Factors in Acute Myeloid LeukemiaFabian Freisleben, Franziska Modemann, Jana Muschhammer, et al.
Medical Oncology (Northwood, London, England)|November 15, 2011
Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥ 10 g/dL: an exploratory analysis of a phase 3 trialJean-Luc Canon, Johan Vansteenkiste, Michael Hedenus, et al.
Histopathology|April 30, 2015
Loss of RNA-binding motif protein 3 expression is associated with right-sided localization and poor prognosis in colorectal cancerNathaniel Melling, Ronald Simon, Martina Mirlacher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2014
The role of relative lymphocyte count as a biomarker for the effect of catumaxomab on survival in malignant ascites patients: results from a phase II/III studyMarkus M Heiss, Michael A Ströhlein, Carsten Bokemeyer, et al.
Annals of Hematology|February 23, 2008
Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulationFlorian Langer, Brigitte Spath, Katja Haubold, et al.
JMIR Research Protocols|July 30, 2020
Development of a Short Instrument for Measuring Health-Related Quality of Life in Oncological Patients for Clinical Use: Protocol for an Observational StudyTheresa Schrage, Mirja Görlach, Christian Stephan Betz, et al.
Pageof 67

Showing results (291-300 of 664) with videos related to

Sort By:
Pageof 67
Virchows Archiv : an International Journal of Pathology|December 14, 2023
Molecular and histopathological characterization of seminoma patients with highly elevated human chorionic gonadotropin levels in the serumChristoph Seidel, Finn-Ole Paulsen, Tim Nestler, et al.
Therapeutic Advances in Medical Oncology|June 4, 2026
Treatment options in platinum-refractory male germ cell cancers: current standards and future directionsMarco Oltrecolli, Domiziana Alaimo, Fabrizio Di Costanzo, et al.
Nature Reviews. Urology|March 9, 2021
Late adverse effects and quality of life in survivors of testicular germ cell tumourMichal Chovanec, Jakob Lauritsen, Mikkel Bandak, et al.
BMC Palliative Care|May 14, 2020
Evaluation of a communication skills training to facilitate addressing palliative care related topics in advanced cancer patients: study protocol of a multicenter randomized controlled trial (PALLI-KOM)Nele Harnischfeger, Hilke M Rath, Anneke Ullrich, et al.
International Journal of Molecular Sciences|October 13, 2021
Mebendazole Mediates Proteasomal Degradation of GLI Transcription Factors in Acute Myeloid LeukemiaFabian Freisleben, Franziska Modemann, Jana Muschhammer, et al.
Medical Oncology (Northwood, London, England)|November 15, 2011
Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥ 10 g/dL: an exploratory analysis of a phase 3 trialJean-Luc Canon, Johan Vansteenkiste, Michael Hedenus, et al.
Histopathology|April 30, 2015
Loss of RNA-binding motif protein 3 expression is associated with right-sided localization and poor prognosis in colorectal cancerNathaniel Melling, Ronald Simon, Martina Mirlacher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2014
The role of relative lymphocyte count as a biomarker for the effect of catumaxomab on survival in malignant ascites patients: results from a phase II/III studyMarkus M Heiss, Michael A Ströhlein, Carsten Bokemeyer, et al.
Annals of Hematology|February 23, 2008
Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulationFlorian Langer, Brigitte Spath, Katja Haubold, et al.
JMIR Research Protocols|July 30, 2020
Development of a Short Instrument for Measuring Health-Related Quality of Life in Oncological Patients for Clinical Use: Protocol for an Observational StudyTheresa Schrage, Mirja Görlach, Christian Stephan Betz, et al.
Pageof 67